Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 718-724

  Jia, Bei Wang ^a   Lian, Xin Liu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; Photodynamic therapy; Porfimer sodium

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE; MIDAZOLAM; PHOTOFRIN; PHOTOSENSITIZING AGENT; SULTAMICILLIN;

BILE DUCT CANCER; BILE DUCT CARCINOMA; CELL DEATH; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LOW LEVEL LASER THERAPY; NONHUMAN; PANCREAS CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; STOMACH CANCER;

BILE DUCT NEOPLASMS; COLONIC NEOPLASMS; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; PANCREATIC NEOPLASMS; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; RECTAL NEOPLASMS; STOMACH NEOPLASMS;

EID: 34250174137     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Maier A, Anegg U, Fell B, Rehak P, et al: Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus. Lasers Surg Med 2000; 26:308-315.
2. Igarashi A, Konno H, Tanaka T, et al: Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer. Toxicol Lett 2003; 145:133-141.
3. Foote CS: Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991; 54:659.
4. Lawen A: Apoptosis-an introduction. Bioessays 2003; 25:888-896.
5. Wallach D, Varfolomeev EE, Malinin NL: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17:331-367.
6. Adams JM, Cory S: Apoptosomes: engines for caspase activation. Curr Opin Cell Biol 2002; 14:715-720.
7. Almeida RD, Manadas BJ, Carvalho AP, et al: Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 2004; 1704:59-86.
8. Overholt BF, Panjehpour M, Haydek JM: Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999; 49:1-7.
9. Barr H, Dix AJ, Kendall C, et al: Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease. Aliment Pharmacol Ther 2001; 15:311-321.
10. Javaid B, Watt P, Krasner N, et al: Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study. Lasers Med Sci 2002; 17:51-56.
11. Fockens P, Van den Brande JH, van Dullemen HM, et al: Endosonographic T-staging of esophageal carcinoma: a learning curve. Gastrointest Endosc 1996; 44:58-62.
12. Murata Y, Suzuki S, Ohta M, et al: Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc 1996; 44:23-28.
13. Torii A, Sakai M, Kajiyama T, et al: Endoscopic aspiration mucosectomy as curative endoscopic surgery; analysis of 24 cases of early gastric cancer. Gastrointest Endosc 1995; 42: 475-479.
14. Takeshita K, Tani M, Inoue H, et al: Endoscopic treatment of early oesophageal or gastric cancer. Gut 1997; 40:123-127.
15. Bonenkamp JJ, Songun I, Hermans J, et al: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745-748.
16. Ris HB, Altermatt HJ, Inderbitzi R, et al: Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 1991; 64:1116-1120.
17. Ell C, Gossner L, May A, et al: Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut 1998; 43:345-349.
18. Patrice T, Foultier MT, Yactayo S, et al: Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Dig Dis Sci 1990; 35:545-552.
19. Nakamura T, Fukui H, Ishii Y, et al: Shape-memory alloy loop snare for endoscopic photodynamic therapy of early gastric cancer. Endoscopy 2000; 32:609-613.
20. Korbelik M, Dougherty GJ: Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res 1999; 59:1941-1946.
21. Takayama T, Sekine T, Makuuchi M, et al: Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000; 356:802-807.
22. Yanai H, Kuroiwa Y, Shimizu N, et al: The pilot experience of immunotherapy-combined photodynamic therapy for advanced gastric cancer in elderly patients. Int J Gastrointest Cancer 2002; 32:139-142.
23. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
24. Ortner MA: Photodynamic therapy in cholangiocarcinomas. Best Pract Res Clin Gastroenterol 2004; 18:147-154.
25. Havlik R, Sbisa E, Tullo A, et al: Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology 2000; 47:927-931.
26. Blom D, Schwartz SI: Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience. Arch Surg 2001; 136:209-215.
27. Born P, Rosch T, Bruhl K, et al: Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gastroenterol 2000; 38:483-489.
28. Berr F, Wiedmann M, Tannapfel A, et al: Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000; 31:291-298.
29. Ortner MA: Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest Endosc Clin N Am 2000; 10:481-486.
30. Ortner ME, Caca K, Berr F, et al: Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003; 125:1355-1363.
31. Rumalla A, Baron TH, Wang KK, et al: Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 2001; 53:500-504.
32. Ortner MA, Liebetruth J, Schreiber S, et al: Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114:536-542.
33. Spinelli P, Mancini A, Dal Fante M: Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy. Semin Surg Oncol 1995; 11:307-318.
34. Shim CS, Cheon YK, Cha SW, et al: Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 2005; 37:425-433.
35. Menzel J, Domschke W: Intraductal ultrasonography (IDUS) of the pancreato-biliary duct system. Personal experience and review of literature. Eur J Ultrasound 1999; 10:105-115.
36. Karnofsky DA, Abelman WH, Craver LF, et al: The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1:634-656.
37. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999; 49:33-64.
38. Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 1992; 326:455-465.
39. Bramhall SR, Allum WH, Jones AG, et al: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82:111-115.
40. Yeo CJ, Cameron JL, Lillemoe KD, et al: Pancreatico-duodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221:721-731.
41. Nitecki SS, Sarr MG, Colby TV, et al: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221:59-66.
42. Neoptolemos JP, Russell RC, Bramhall S, et al: Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 1997;84:1370-1376.
43. Trede M, Schwall G, Saeger HD: Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990; 211:447-458.
44. Liu CD, Kwan D, Saxton RE, et al: Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J Surg Res 2000; 93:137-143.
45. Hajri A, Coffy S, Vallat F, et al: Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo. Br J Surg 1999; 86:899-906.
46. Schroder T, Chen IW, Sperling M, et al: Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma. J Surg Oncol 1988; 38:4-9.
47. Keller P, Sowinska M, Tassetti V, et al: Photodynamic imaging of a rat pancreatic cancer with pheophorbide a Photochem Photobiol 1996; 63:860-867.
48. Evrard S, Keller P, Hajri A, et al: Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg 1994; 81:1185-1189.
49. Mlkvy P, Messmann H, Pauer M, et al: Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer 1996; 73:1473-1479.
50. Ayaru L, Bown SG, Pereira SP: Photodynamic therapy for pancreatic and biliary tract carcinoma. Int J Gastrointest Cancer 2005; 35:1-13.
51. Bown SG, Rogowska AZ, Whitelaw DE, et al: Photodynamic therapy for cancer of the pancreas. Gut 2002; 50:549-557.
52. Chan HH, Nishioka NS, Mino M, et al: EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest Endosc 2004; 59:95-99.
53. Wiedmann MW, Caca K: General principles of photodynamic therapy (PDT) and gastrointestinal applications. Curr Pharm Biotechnol 2004; 5:397-408.
54. McCaughan JS Jr: Miscellaneous treatments. In: JS McCaughan Jr (Ed.). Photodynamic Therapy for Malignancies: Clinical Manual. Austin, TX: Landes, 1992; pp.135-144.
55. Barr H, Krasner N, Boulos PB, et al: Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990; 77:93-96.
56. Herrera-Ornelas L, Petrelli NJ, Mittelman A, et al: Photodynamic therapy in patients with colorectal cancer. Cancer 1986; 57:677-684.
57. Allardice JT, Abulafi AM, Grahn MF, et al: Adjuvant intraoperative photodynamic therapy for colorectal carcinoma: a clinical study. Surg Oncol 1994; 3:1-10.
58. Abulafi AM, Allardice JT, Williams NS, et al: Photodynamic therapy for malignant tumors of the ampulla of Vater. Gut 1995; 36:853-856.
59. Abulafi AM, DeJode ML, Allardice JT, et al: Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer. Br J Surg 1997; 84:368-371.
60. Hamblin MR, Del Governatore M, Rizvi I, et al: Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer 2000; 83:1544-1551.
61. Rovers JP, Schuitmaker JJ, Vahrmeljer AL, et al: Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases. Br J Cancer 1998; 77:2098-2103.
62. Fisher AM, Rucker N, Wong S, et al: Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines. J Photochem Photobiol B 1998; 42:104-107.
63. Nakamura T, Fukui H, Ishii Y, et al: Photodynamic therapy with polypectomy for rectal cancer. Gastrointest Endosc 2003; 57:266-269.
64. Baron TH: Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001; 344:1681-1687.
65. Scholefield JH: Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Tech Coloproctol 2004; 8:200.
66. Rovers JP, Saarnak AE, Molina A, et al: Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Br J Cancer 1999; 81:600-608.
67. Berr F: Photodynamic therapy for cholangiocarcinoma. Semin Liver Dis 2004; 24:177-187.
68. Dolmans DE, Kadambi A, Hill JS, et al: Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res 2002; 62:4289-4294.
69. Ruoslahti E: Specialization of tumor vasculature. Nat Rev Cancer 2002; 2:83-90.
70. Vrouenraets MB, Visser GW, Stewart FA, et al: Development of meta- tetrahydroxyphenylchlorin-monoelonal antibody conjugates for photoimmunotherapy. Cancer Res 1999; 59:1505-1513.
71. Goff BA, Blake J, Bamberg MP, et al: Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Br J Cancer 1996; 74:1194-1198.
72. Molpus KL, Hamblin MR, Rizvi I, et al: Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photo-immunoconjugates. Gynecol Oncol 2000; 76:397-404.